Find Reports

Select Report Type

Reimbursement Review

Displaying 676 - 700 of 1422

Please scroll or swipe to the right to view the full content.

Title	Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Sylvant Multicentric Castleman...	Sylvant	Siltuximab	pcodr_provfund_sylvant_mcd.pdf pcodr_siltuximab_sylvant_mcd_fn_rec.pdf pcodr_siltuximab_sylvant_mcd_fn_cgr.pdf pcodr_siltuximab_sylvant_mcd_fn_egr.pdf pcodr_siltuximab_sylvant_mcd_in_rec.pdf pcodr_siltuximab_sylvant_mcd_pagfdk.pdf pcodr_siltuximab_sylvant_mcd_fdk_janssen.pdf pcodr_siltuximab_sylvant_mcd_coi_cord.pdf	Multicentric Castleman's disease (MCD)	Reimburse with clinical criteria and/or conditions	Complete	Jan 30, 2015	Jun 22, 2015	PC0052-000
Xtandi First Line mCRPC - Deta...	Xtandi	Enzalutamide	pcodr-provfund_xtandi_mcrpc1stline.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_fn_rec.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_fn_cgr.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_fn_egr.pdf pcodr_enzalutamide_xtandi_1stln_mcrcp_in_rec.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_pagfdk.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_fdbk_astellas.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_ptfdk_pcc.pdf pcodr_enzalutamide_xtandi_1stln_mcrpc_coi_pcc.pdf	First Line Metastatic Castration-Resistant Prostate Cancer	Reimburse with clinical criteria and/or conditions	Complete	Oct 2, 2014	Jun 22, 2015	PC0044-000
Alemtuzumab	Lemtrada	Alemtuzumab	cdr_SR0405_Lemtrada.pdf cdr-complete-SR0405-Lemtrada-June-22-2015.pdf SR0405_Lemtrada_RRMS_CL_Report.pdf SR0405_Lemtrada_RRMS_PE_Report.pdf SR0405 Lemtrada_RRMS_PI_Submissions.pdf	Multiple sclerosis, relapsing-remitting	List with criteria/condition	Complete	Nov 27, 2014	Jun 18, 2015	SR0405-000
Ombitasvir/paritaprevir/ritona...	Holkira Pak	Ombitasvir/paritaprevir/ritonavir and dasabuvir	SR0406 Holkira Pak.pdf SR0406-Holkira-Pak-July-22-15-e.pdf SR0406_HolkiraPak_CL_Report.pdf SR0406_HolkiraPak_PE_Report.pdf SR0406_HolkiraPak_PI_Submissions.pdf	Hepatitis C, chronic	List with clinical criteria and/or conditions	Complete	Dec 3, 2014	Jun 18, 2015	SR0406-000
Brinzolamide / brimonidine	Simbrinza	Brinzolamide / brimonidine	cdr_SR0403_Simbrinza.pdf cdr_complete_SR0403_Simbrinza_June-19_2015.pdf SR0403_Simbrinza_PI_Submissions.pdf SR0403_Simbrinza_FDC_Review_Report.pdf	Glaucoma and ocular hypertension	List	Complete	Nov 3, 2014	Jun 17, 2015	SR0403-000
Azelastine HCl and fluticason...	Dymista	Azelastine HCl and fluticasone propionate	cdr_SR0408_Dymista.pdf cdr_complete_SR0408_Dymista_June-19-2015.pdf SR0408_Dymista_CL_Report.pdf SR0408_Dymista_PE_Report.pdf SR0408_Dymista_PI_Submissions.pdf	Seasonal allergic rhinitis	Do not list	Complete	Dec 9, 2014	Jun 17, 2015	SR0408-000
Avastin for Ovarian Cancer - D...	Avastin	Bevacizumab	pcodr_provfund_avastin-oc.pdf pcodr_bevacizumab_avastin_oc-fn_rec.pdf pcodr_bevacizumab_avastin_oc-fn_cgr.pdf pcodr_bevacizumab_avastin_oc-fn_egr.pdf pcodr_bevacizumab_avastin_oc_in_rec.pdf pcodr_bevacizumab_avastin_oc_pagfdk.pdf pcodr_bevacizumab_avastin_oc_fdk_hlroche.pdf pcodr_bevacizumab_avastin_oc_ptfdk_occ.pdf pcodr_bevacizumab_avastin_oc_coi_occ_0.pdf	Ovarian Cancer	Reimburse with clinical criteria and/or conditions	Complete	Nov 28, 2014	Jun 4, 2015	PC0047-000
Istodax for Peripheral T-Cell ...	Istodax	Romidepsin	pcodr_provfund_istodax_ptcl.pdf pcodr_romidepsin_istodax_ptcl_fn_rec.pdf pcodr_romidepsin_istodax_ptcl_fn_cgr.pdf pcodr_romidepsin_istodax_ptcl_fn_egr.pdf pcodr_romidepsin_istodax_ptcl_in_rec.pdf pcodr_romidepsin_istodax_ptcl_pagfdk.pdf pcodr_romidepsin_istodax_ptcl_fdk_celgene.pdf	Peripheral T-Cell Lymphoma	Reimburse with clinical criteria and/or conditions	Complete	Dec 1, 2014	May 19, 2015	PC0048-000
Aflibercept	Eylea	Aflibercept	cdr_SR0396_Eylea_DME.pdf SR0396_EyleaDME_CL_Report.pdf SR0396_EyleaDME_PE_Report.pdf cdr_complete_SR0396_Eylea-DME_May-11-15.pdf SR0396 Eylea DME_PI_Submissions.pdf	Macular edema, diabetic	List with clinical criteria and/or conditions	Complete	Sep 16, 2014	May 7, 2015	SR0396-000
Aflibercept	Eylea	Aflibercept	cdr_SR0401_Eylea_CRVO.pdf cdr_complete_SR0401_Eylea-CRVO_May-11-15.pdf SR0401_EyleaCRVO_CL_Report.pdf SR0401_EyleaCRVO_PE_Report.pdf SR0401_EyleaCRVO_PI_Submissions.pdf	Macular edema, central retinal vein occlusion	List with clinical criteria and/or conditions	Complete	Oct 17, 2014	May 7, 2015	SR0401-000
Apixaban	Eliquis	Apixaban	cdr_SR0397_Eliquis_VTE.pdf cdr_complete_SR0397_Eliquis-VTE_May-11-15.pdf SR0397_EliquisVTE_CL_Report.pdf SR0397_EliquisVTE_PE_Report.pdf SR0397_Eliquis_VTE_PI_Submissions.pdf	Venous thromboembolic events, treatment and prevention of recurrence	List with clinical criteria and/or conditions	Complete	Sep 18, 2014	May 7, 2015	SR0397-000
Omalizumab	Xolair	Omalizumab	cdr_SR0398_Xolair_CIU.pdf cdr_complete_SR0398_Xolair-CIU_May-11-15.pdf SR0398_XolairCIU_CL_Report.pdf SR0398_XolairCIU_PE_Report.pdf SR0398 Xolair_Template_PI_Submissions.pdf	Chronic idiopathic urticaria	List with clinical criteria and/or conditions	Complete	Sep 22, 2014	May 7, 2015	SR0398-000
Bosulif for Chronic Myeloid Le...	Bosulif	Bosutinib	pcodr_profund_boustinib_bosulif_cml.pdf pcodr_bosutinib_bosulif_cml_fn_rec.pdf pcodr_bosutinib_bosulif_cml_fn_cgr.pdf pcodr_bosutinib_bosulif_cml_fn_egr.pdf pcodr_bosutinib_bosulif_cml_in_rec.pdf pcodr_bosutinib_bosulif_cml_pagfdk.pdf pcodr_bosutinib_bosulif_cml_fdk_pfizer.pdf pcodr_bosutinib_bosulif_cml_coi_cmlsc.pdf	Chronic Myeloid Leukemia	Reimburse with clinical criteria and/or conditions	Complete	May 30, 2014	Apr 21, 2015	PC0039-000
Dolutegravir / abacavir / lami...	Triumeq	Dolutegravir / abacavir / lamivudine	cdr_SR0387_Triumeq.pdf cdr_complete_SR0387_Triumeq_Apr-21-15.pdf SR0387_Triumeq_FDC_Review_Report_e.pdf	HIV Infection	List with criteria/condition	Complete	Jul 31, 2014	Apr 17, 2015	SR0387-000
Tofacitinib	Xeljanz	Tofacitinib	cdr_SR0380_Xeljanz.pdf cdr_complete_SR0380_Xeljanz_Apr-21-15.pdf SR0380_Xeljanz_CL_Report.pdf SR0380_Xeljanz_PE_Report.pdf	Arthritis, rheumatoid	List with criteria/condition	Complete	May 5, 2014	Apr 17, 2015	SR0380-000
Certolizumab pegol	Cimzia	Certolizumab pegol	cdr_SR0385_Cimzia.pdf cdr_complete_SR0385_Cimzia-AS_Apr-21-15.pdf SR0385_Cimzia_AS_PI_Submissions.pdf SR0385_CimziaAS_CL_Report_e.pdf SR0385_CimziaAS_PE_Report_e.pdf	Ankylosing spondylitis	List with criteria/condition	Complete	Jun 23, 2014	Apr 17, 2015	SR0385-000
Lomitapide	Juxtapid	Lomitapide	cdr_SR0386_Juxtapid.pdf cdr_complete_SR0386_Juxtapid-Apr-21_15.pdf SR0386_Juxtapid_CL_Report_e.pdf SR0386_Juxtapid_PE_Report_e.pdf media:document:1613e67a-34b5-425b-91a2-3240102d189c	Hypercholesterolemia, homozygous familial	Do not list	Complete	Jul 8, 2014	Apr 17, 2015	SR0386-000
Certolizumab pegol	Cimzia	Certolizumab pegol	SR0394 Cimzia PsA.PDF cdr_complete_SR0394_Cimzia-PsA_Apr-21-15.pdf SR0394_CimziaPsA_CL_Report.pdf SR0394_CimziaPsA_PE_Report.pdf SR0394 Cimzia PsA_PI_Submissions.pdf	Arthritis, psoriatic	List with criteria/condition	Complete	Sep 2, 2014	Apr 17, 2015	SR0394-000
Rifaximin	Zaxine	Rifaximin	cdr_SR0388_Zaxine.pdf cdr_complete_SR0388_Zaxine-Apr-20-15.pdf SR0388_Zaxine_CL_Report_e.pdf SR0388_Zaxine_PE_Report_e.pdf SR0388 Zaxine_PI_Submissions_e.pdf	Hepatic encephalopathy	List with criteria/condition	Complete	Aug 5, 2014	Apr 16, 2015	SR0388-000
Eslicarbazepine acetate	Aptiom	Eslicarbazepine acetate	cdr_SR0391_Aptiom.pdf cdr_complete_SR0391_Aptiom_Apr-20-15.pdf SR0391_Aptiom_CL_Report.pdf SR0391_Aptiom_PE_Report.pdf SR0391 Aptiom_PI_Submissions_e.pdf	Epilepsy, partial-onset seizures	List with criteria/condition	Complete	Aug 15, 2014	Apr 16, 2015	SR0391-000
Everolimus	Afinitor	Everolimus	cdr_SR0376_Afinitor_SEGA.pdf cdr_compelte_SR0376_Afinitor_Apr-17-15.pdf SR0376 Afinitor SEGA_Template_PI_Submissions.pdf SR0376_AfinitorSEGA_CL_Report_e.pdf SR0376_AfinitorSEGA_PE_Report.pdf	Subependymal giant cell astrocytoma associated with tuberous sclerosis complex	Do not list	Complete	Mar 19, 2014	Apr 15, 2015	SR0376-000
Pirfenidone	Esbriet	Pirfenidone	cdr_SR0393_Esbriet.pdf cdr_compelte_SR0393_Esbriet_Apr-17-15.pdf SR0393_Esbriet_CL_Report_resub.pdf SR0393_Esbriet_PE_Report_resub.pdf	Idiopathic pulmonary fibrosis	List with criteria/condition	Complete	Aug 29, 2014	Apr 15, 2015	SR0393-000
Elosulfase alfa	Vimizim	Elosulfase alfa	cdr_SR0389_Vimizim.pdf SR0389_complete_Vimizim_Mar-27-15.pdf SR0389_Vimizim_CL_Report_e.pdf SR0389_Vimizim_PE_Report_e.pdf SR0389 Vimizim_PI_Submissions_e.pdf	Mucopolysaccharidosis IVA (Morquio A syndrome)	Do not list	Complete	Aug 5, 2014	Mar 25, 2015	SR0389-000
Avastin for Cervical Cancer - ...	Avastin	Bevacizumab	pcodr_provfund_avastin-cc.pdf pcodr-avastincc-fn-rec.pdf pcodr-avastin-cc-fn-cgr.pdf pcodr-avastin-cc-fn-egr.pdf pcodr-avastin-cc-in-rec.pdf pcodr-avastincc-pagfdk.pdf pcodr-avastincc-fdk-hlr.pdf pcodr-avastincc-fdk-occ.pdf pcodr-avastincc-coi-occ.pdf	Cervical Cancer	Reimburse with clinical criteria and/or conditions	Complete	Oct 27, 2014	Mar 23, 2015	PC0045-000
Eltrombopag	Revolade	Eltrombopag	cdr_SR0377_Revolade.pdf cdr_complete_SR0377_Revolade_Mar-23-2015_e.pdf SR0377_RevoladeTCP_CL_Report.pdf SR0377_RevoladeTCP_PE_Report.pdf SR0377 Revolade TCP_PI_Submissions.pdf	Thrombocytopenia associated with chronic hepatitis c infection	List with criteria/condition	Complete	Mar 31, 2014	Mar 18, 2015	SR0377-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 600 of 600

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 676 - 700 of 2132

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
pembrolizumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Mar 20, 2023	Reimbursement Review		Complete	PC0295-000
Formulary Management of Targeted Immune Modulators for Ulcerative Colitis: Environmental Scan	Formulary Management of Targeted Immune Modulators in Ulcerative Colitis	Mar 16, 2023	Health Technology Review	Environmental Scan	Completed	ES0366-000
eptinezumab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Mar 15, 2023	Reimbursement Review		Complete	SR0743-000
Longevity of Partial and Complete Dentures	Longevity of Partial and Complete Dentures	Mar 14, 2023	Health Technology Review	Rapid Review	Completed	RC1474-000
pegvaliase	Memorandum report to CADTH Response to the Procedural Review Panel’s Memorandum Report on the Procedural R…Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Mar 13, 2023	Reimbursement Review		Complete	SR0712-000
Dental Bridges for Partial Tooth Loss	Dental Bridges for Partial Tooth Loss	Mar 13, 2023	Health Technology Review	Peer-reviewed Summary with Critical Appraisal	Completed	RD0068-000
Policies for Pediatric Medicines		Mar 10, 2023	Health Technology Review	Environmental Scan	In Progress	ES0376-000
Hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer	Final Report	Mar 8, 2023	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0018-000
Automatic Stop Orders for Opioids	Automatic Stop Orders for Opioids	Mar 8, 2023	Health Technology Review	Rapid Review	Completed	RC1473-000
Point-of-Care Tests for Pancreatitis	Point-of-Care Tests for Pancreatitis	Mar 6, 2023	Horizon Scan	Health Technology Update	Completed	EN0045-000
Dental Sealants for the Prevention of Dental Caries	Dental Sealants for the Prevention of Dental Caries	Mar 1, 2023	Health Technology Review	Rapid Review	Completed	RC1471-000
mepolizumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Feb 27, 2023	Reimbursement Review		Complete	SR0735-000
guselkumab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Feb 27, 2023	Reimbursement Review		Complete	SR0733-000
edaravone	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Rétroaction des intervenants sur la recommandations provisoire	Feb 24, 2023	Reimbursement Review		Complete	SR0727-000
Nabilone for the Treatment of Post-Traumatic Stress Disorder: A 2023 Update	Nabilone for the Treatment of Post-Traumatic Stress Disorder: A 2023 Update	Feb 24, 2023	Health Technology Review	Summary with Critical Appraisal	Completed	RC1472-000
dalbavancin	Recommendation and Reasons Clinical and Pharmacoeconomic Combined Report Stakeholder Feedback on Draft Recommendation	Feb 23, 2023	Reimbursement Review		Complete	SR0728-000
pitolisant hydrochloride	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Feb 22, 2023	Reimbursement Review		Complete	SR0715-000
ozanimod	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Feb 22, 2023	Reimbursement Review		Complete	SR0714-000
Bladder Scanners in Personal Care Homes	Bladder Scanners in Personal Care Homes	Feb 21, 2023	Health Technology Review	Rapid Review	Completed	RC1470-000
Wastewater Surveillance for Communicable Disease	Wastewater Surveillance for Communicable Disease	Feb 21, 2023	Horizon Scan	Emerging Health Technologies	Completed	EH0114-000
CADTH Pharmaceutical Reviews Update — Issue 34		Feb 16, 2023	Reimbursement Review	Pharmaceutical Review Update
Sotrovimab for the Treatment of COVID-19	Sotrovimab for the Treatment of COVID-19	Feb 14, 2023	Health Technology Review	Rapid Review	Completed	RC1468-000
tafasitamab	Memorandum report to CADTH Response to the Procedural Review Panel’s Memorandum Report Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Feb 10, 2023	Reimbursement Review		Complete	PC0266-000
Tenecteplase for Acute Ischemic Stroke	Tenecteplase for Acute Ischemic Stroke	Feb 9, 2023	Health Technology Review	Rapid Review	Completed	RC1469-000
cariprazine	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Feb 8, 2023	Reimbursement Review		Complete	SR0718-000